Syndax Pharmaceuticals Inc (SNDX)

12:53 PM

Syndax Pharmaceuticals Inc. stock trend outlook and recovery pathMarket Sentiment Summary & Reliable Entry Point Alerts - newser.com

12:53 PM

Oct 12, 2025

Heatmap analysis for Syndax Pharmaceuticals Inc. and competitors2025 Market Outlook & Community Verified Trade Alerts - newser.com

Oct 12, 2025

Oct 12, 2025

Evaluating Syndax Pharmaceuticals Inc. with trendline analysis2025 Pullback Review & Reliable Price Breakout Alerts - newser.com

Oct 12, 2025

Oct 10, 2025

Will Syndax Pharmaceuticals Inc. stock see insider buying2025 EndofYear Setup & Verified Chart Pattern Signals - newser.com

Oct 10, 2025

Oct 10, 2025

Published on: 2025-10-10 04:00:50 - newser.com

Oct 10, 2025

Oct 10, 2025

Menin Inhibitors Drug Market Report 2025: Price, Sales & Clinical Trials Insights 2024-2028 - GlobeNewswire Inc.

Oct 10, 2025

Oct 10, 2025

Order flow analysis tools used on Syndax Pharmaceuticals Inc.2025 Retail Activity & Fast Gain Swing Trade Alerts - newser.com

Oct 10, 2025

Oct 09, 2025

Syndax resumed with Buy at Stifel on newly launched drugs - MSN

Oct 09, 2025

Oct 09, 2025

Analyzing drawdowns of Syndax Pharmaceuticals Inc. with statistical toolsPortfolio Value Summary & Daily Volume Surge Signals - newser.com

Oct 09, 2025

Oct 09, 2025

Published on: 2025-10-09 05:04:06 - newser.com

Oct 09, 2025

Oct 09, 2025

Should you hold or exit Syndax Pharmaceuticals Inc. nowJuly 2025 Opening Moves & Low Risk Investment Opportunities - newser.com

Oct 09, 2025

Oct 09, 2025

Syndax Pharmaceuticals (NASDAQ:SNDX) Given Sell (E+) Rating at Weiss Ratings - MarketBeat

Oct 09, 2025

Oct 07, 2025

Is Syndax Pharmaceuticals Inc 1T3 a good long term investmentValue Traps to Avoid & Small Investment Portfolio - earlytimes.in

Oct 07, 2025

Oct 07, 2025

Syndax Pharmaceuticals Stock Falls After Data From Mid-Stage Study Of Revumenib In Form Of Blood Cancer - AOL.com

Oct 07, 2025

Oct 06, 2025

Technical analysis overview for Syndax Pharmaceuticals Inc. stockJuly 2025 Trends & AI Driven Price Forecasts - newser.com

Oct 06, 2025

Oct 06, 2025

Research Analysts Offer Predictions for SNDX FY2027 Earnings - MarketBeat

Oct 06, 2025

Oct 05, 2025

Will October's FDA Decision Be A Shot In The Arm For Revuforj's Expansion? - RTTNews

Oct 05, 2025

Oct 05, 2025

Is Syndax Pharmaceuticals Inc. (1T3) stock considered safe havenJuly 2025 Rallies & Short-Term High Return Strategies - newser.com

Oct 05, 2025

Oct 05, 2025

Measuring Syndax Pharmaceuticals Inc.’s beta against major indices2025 Geopolitical Influence & Reliable Volume Spike Alerts - newser.com

Oct 05, 2025

Oct 05, 2025

Comparing Syndax Pharmaceuticals Inc. in custom built stock radarsProduct Launch & Real-Time Volume Analysis Alerts - newser.com

Oct 05, 2025

Oct 04, 2025

Syndax’s Revumenib Added to NCCN AML Guidelines Ahead of October 25 FDA Decision - Yahoo

Oct 04, 2025

Oct 04, 2025

Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - GlobeNewswire

Oct 04, 2025

Oct 03, 2025

BRIEF-Syndax Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule - The Sunday Guardian

Oct 03, 2025

Oct 03, 2025

Syndax Pharmaceuticals reports inducement grants under Nasdaq Listing Rule - MarketScreener

Oct 03, 2025

Oct 03, 2025

Does Syndax Pharmaceuticals Inc. qualify in momentum factor screeningStop Loss & Daily Entry Point Trade Alerts - newser.com

Oct 03, 2025

Oct 03, 2025

138,900-Share Grant: Syndax Awards to 10 New Employees; Options Vest Monthly Under Inducement Plan - Stock Titan

Oct 03, 2025

Sep 30, 2025

Regulatory Milestone and Analyst Optimism Fuel Momentum for Syndax Pharmaceuticals - MSN

Sep 30, 2025

Sep 29, 2025

Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Receives Consensus Recommendation of "Buy" from Analysts - MarketBeat

Sep 29, 2025

Sep 28, 2025

What analysts say about Syndax Pharmaceuticals Inc stockEarnings Revision Updates & Minimize Portfolio Damage with Warnings - earlytimes.in

Sep 28, 2025

Sep 25, 2025

When Will Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Turn A Profit? - Yahoo Finance

Sep 25, 2025

Sep 22, 2025

Syndax Pharmaceuticals (NASDAQ:SNDX) Earns "Buy" Rating from BTIG Research - MarketBeat

Sep 22, 2025

Sep 21, 2025

Risk On: Can Syndax Pharmaceuticals Inc stock double in the next yearGap Down & Real-Time Buy Zone Alerts - خودرو بانک

Sep 21, 2025

Sep 20, 2025

Multiple Insiders Sold Syndax Pharmaceuticals Shares Presenting Weak Signs For Investors - 富途牛牛

Sep 20, 2025

Sep 20, 2025

Syndax Pharmaceuticals Nears Critical Regulatory Milestone - AD HOC NEWS

Sep 20, 2025

Sep 19, 2025

Highs Report: What’s next for IRIDEX Corporation stockBreakout Watch & Daily Profit Focused Stock Screening - khodrobank.com

Sep 19, 2025

Sep 19, 2025

Update Recap: Can CZWI disrupt its industryEarnings Recap Report & Verified Entry Point Signals - khodrobank.com

Sep 19, 2025

Sep 19, 2025

BTIG Reiterates Buy Rating on SNDX with $56 Price Target | SNDX Stock News - GuruFocus

Sep 19, 2025

Sep 19, 2025

3 Potential Biotech Acquisition Targets - Seeking Alpha

Sep 19, 2025

Sep 19, 2025

SNDX: Revumenib Gains Key NCCN Recommendation for AML Treatment - GuruFocus

Sep 19, 2025